Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic DOI Open Access

Wilson Sy

Medical & Clinical Research, Journal Year: 2024, Volume and Issue: 9(2), P. 01 - 21

Published: Feb. 15, 2024

Macro-data during the COVID-19 pandemic in United Kingdom (UK) are shown to have significant data anomalies and inconsistencies with existing explanations. This paper shows that UK spike deaths, wrongly attributed April 2020, was not due SARS-CoV-2 virus, which largely absent, but widespread use of Midazolam injections were statistically very highly correlated (coefficient over 90 percent) excess deaths all regions England 2020. Importantly, remained elevated following mass vaccination 2021, uncorrelated COVID vaccination, while remaining significantly injections. The persistent suggests a possible policy systemic euthanasia. Unlike Australia, where assessing statistical impact on is relatively straightforward, closely associated other medical intervention. iatrogenic caused by euthanasia from also, likely their relative impacts difficult measure data, causal proximity Global investigations epidemiology, based only disease may be inaccurate, neglect confounding factors some countries.

Language: Английский

COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes DOI Open Access
Claire Rogers, James A. Thorp,

Kirstin Cosgrove

et al.

Published: June 19, 2024

Introduction: This population-based retrospective cohort study assesses rates of adverse events (AEs) involving cerebral thromboembolism (CTE) after COVID-19 vaccines. Methods: Data were collected from the U.S. Centers for Disease Control and Prevention (CDC) Food Drug Administration (FDA) Vaccine Adverse Event Reporting System (VAERS) database January 1, 1990 to December 31, 2023. CTE AEs vaccines compared those influenza all other using proportional reporting ratio (PRR) analysis by time. Results: There are 5137 reported in 3 years (36 months) 52 over past 34 (408 282 (excluding COVID-19) months). The PRR’s significant when comparing time that (p < 0.0001) or 0.0001). PRR (95% confidence intervals) vaccine vs is 1120 interval (723-1730), p others 207 (144-296), Cerebral venous female predominant with a female/male odds 1.63 (1.52-1.74), Conversely, arterial has nonsignificant male preponderance. far more common than 36 months an (OR) 14.8 14.0-15.5, Atrial fibrillation, most identifiable cause thromboembolism, occurs commonly as 123 CI 88.3-172, Conclusions: alarming breach safety signal threshold concerning thrombosis even An immediate global moratorium on use necessary absolute contraindication women reproductive age.

Language: Английский

Citations

2
COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes DOI Open Access
Claire Rogers, James A. Thorp,

Kirstin Cosgrove

et al.

Published: June 18, 2024

Introduction: This population-based retrospective cohort study assesses rates of adverse events (AEs) involving cerebral thromboembolism (CTE) after COVID-19 vaccines. Methods: Data were collected from the U.S. Centers for Disease Control and Prevention (CDC) Food Drug Administration (FDA) Vaccine Adverse Event Reporting System (VAERS) database January 1, 1990 to December 31, 2023. CTE AEs vaccines compared those influenza all other using proportional reporting ratio (PRR) analysis by time. Results: There are 5137 reported in 3 years (36 months) 52 over past 34 (408 282 (excluding COVID-19) months). The PRR’s significant when comparing time that (p < 0.0001) or 0.0001). PRR (95% confidence intervals) vaccine vs is 1120 interval (723-1730), p others 207 (144-296), Cerebral venous female predominant with a female/male odds 1.63 (1.52-1.74), Conversely, arterial has nonsignificant male preponderance. far more common than 36 months an (OR) 14.8 14.0-15.5, Atrial fibrillation, most identifiable cause thromboembolism, occurs commonly as 123 CI 88.3-172, Conclusions: alarming breach safety signal threshold concerning thrombosis even An immediate global moratorium on use necessary absolute contraindication women reproductive age.

Language: Английский

Citations

1
Early Indication of Long-Term Impact of COVID Injections DOI Open Access

Wilson Sy

Medical & Clinical Research, Journal Year: 2023, Volume and Issue: unknown

Published: Oct. 20, 2023

The latest Australian mortality data provide the first clear statistical indication that COVID-19 injections are doing long-term harm to population, where further likely cause greater proportionate harm. causal relationship between COVID and excess deaths discovered in earlier studies, is shown be accurately predictive, because Australia arguably an excellent natural “controlled” experiment on effects of intervention. Significantly, this bad news about also relevant for rest world

Language: Английский

Citations

1
Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic DOI Open Access

Wilson Sy

Medical & Clinical Research, Journal Year: 2024, Volume and Issue: 9(2), P. 01 - 21

Published: Feb. 15, 2024

Macro-data during the COVID-19 pandemic in United Kingdom (UK) are shown to have significant data anomalies and inconsistencies with existing explanations. This paper shows that UK spike deaths, wrongly attributed April 2020, was not due SARS-CoV-2 virus, which largely absent, but widespread use of Midazolam injections were statistically very highly correlated (coefficient over 90 percent) excess deaths all regions England 2020. Importantly, remained elevated following mass vaccination 2021, uncorrelated COVID vaccination, while remaining significantly injections. The persistent suggests a possible policy systemic euthanasia. Unlike Australia, where assessing statistical impact on is relatively straightforward, closely associated other medical intervention. iatrogenic caused by euthanasia from also, likely their relative impacts difficult measure data, causal proximity Global investigations epidemiology, based only disease may be inaccurate, neglect confounding factors some countries.

Language: Английский

Citations

0